Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of Recurrent Hypoglycemia on Brain Ketone Metabolism in Type 1 Diabetes
NCT02471040Phase 1Completed
- Sponsor
- Yale University
- Start
- May 2013
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of 3-hydroxybutyrate in hypoglycemia (3 arms), sponsored by Yale University. Primary endpoint: Cognitive Function. Started May 2013; status: completed.
02
Drugs
3-hydroxybutyrate
03
Conditions
hypoglycemia
Beyond the preview
Go deeper on NCT02471040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02471040.